All
Day 2 Recap: 50th Annual SPD Dermatology Conference 2025
Catch up on coverage from the second day of the 50th Annual Society for Pediatric Dermatology Meeting in Seattle, Washington.
Scratching the Itch of Pruritus With Adam Friedman, MD
DERM 2025 featured tips and tricks for a thorough pruritus diagnosis and treatment strategy from Adam Friedman, MD.
Reviewing Hemangiomas and Capillary Malformations and their Associated Risks
At Elevate-Derm Summer, Jim Treat, MD, outlined diagnostic limitations of imaging and the importance of recognizing capillary malformation patterns linked to other diseases.
Lisa Swanson, MD, FAAD, Highlights Expanding Pediatric Treatment Options
Swanson discussed new and upcoming therapeutics, and how she approaches treatment options with caregivers.
Beyond the Surface: Walter Liszewski, MD, on New Frontiers in Chronic Skin Conditions
Discover Walter Liszewski, MD's insights on emerging therapies and consumer safety at Elevate-Derm Summer 2025, focusing on allergy research and treatment advancements.
Lawrence Schachner, MD, Reflects on Career, Mentorship, and Innovation
Schachner was the 2025 recipient of the AAP Alvin H. Jacobs award at the 50th annual SPD meeting.
Expanding Treatment Options to Pediatric Populations: A Conversation With Lisa Swanson, MD, at DERM 2025
Lisa Swanson, MD, discusses the unmet needs in pediatric dermatology at the DERM 2025 conference.
Forever Chemicals: Michelle Hure, MD, Discusses Clinical Concerns About PFAS in Dermatology
Hure details what clinicians need to know to protect their patients.
Leveraging Molecular Diagnostics for Tailored Skin Cancer Care
Discover how gene expression profiling transforms melanoma and SCC management, enhancing personalized treatment strategies and improving patient outcomes in skin cancer care.
Clinical Pearls, Practical Approaches, and New Perspectives: Highlights From the First Days of DERM 2025
The DERM 2025 midway recap includes tips for atopic dermatitis, chronic hand eczema, and pruritus.
A Rheum With a View at DERM 2025: Looking at Cutaneous Lupus
Rheumatologist Karim Ladak, MD, shared diagnostic and treatment tips for cutaneous lupus at DERM 2025.
Day 1 Recap: Elevate-Derm Summer Conference 2025
Catch up on coverage from the first day of the 2025 Elevate-Derm Summer Conference held in Park City, Utah.
Day 1 Recap: 50th Annual SPD Dermatology Conference 2025
Catch up on coverage from the first day of the 50th Annual Society for Pediatric Dermatology Meeting in Seattle, Washington.
New Trial Explores AD Treatment in Patients Under 2
Explore the INTEGUMENT-INFANT study, assessing roflumilast cream's safety and efficacy for infants with atopic dermatitis in a groundbreaking trial.
Practical Approaches to Patch Testing and JAK Inhibitor Optimization in Atopic Dermatitis
Walter Liszewski, MD, highlights the clinical impact of patch testing and shares strategies for selecting and dosing JAK inhibitors at Elevate-Derm Summer.
Elevate-Derm 2025: Emerging Trends and Therapies in Clinical Research
Discover innovative research pearls at the Elevate-Derm Summer Conference 2025, focusing on psoriasis, skin cancer, and more.
Obesity Care Expands Toolkit for Pediatric Specialists
Discover insights from SPD 2025 on pediatric obesity treatment, emphasizing multidisciplinary care and innovative therapies.
Remibrutinib Shows Rapid and Sustained Improvement in CSU Activity Score Bands
New findings at Elevate Derm highlight remibrutinib's rapid and sustained efficacy in reducing chronic spontaneous urticaria symptoms, offering hope for patients.
Poster Presented at DERM 2025: High Impact Areas See Positive Results in Icotrokinra Phase 3 Trial
Psoriasis in high impact areas responded well to icotrokinra, presenting a potential exciting option for patients.
Familiar Faces at SPD 2025
Rethinking “Monotherapy Brain” in Complex Skin Disease
At the DERM 2025 conference, Scott Boswell, MD, shares tips for combining therapies.
UnlIMMited Data Demonstrate Risankizumab Efficacy in Genital and Scalp Psoriasis
James Song, MD, discussed his UnlIMMited DERM 2025 poster detailing risankizumab's efficacy for genital and scalp psoriasis.
FDA Approves LEO Pharma's Delgocitinib for Adults With Moderate to Severe Chronic Hand Eczema
The approval makes delgocitinib cream the first and only approved therapy in the US for CHE in adults.
POLL: Will You Be Attending Elevate-Derm Summer This Weekend?
Join Dermatology Times at the 2025 Elevate-Derm Summer Conference for expert insights and live updates from Park City, Utah.
Conference Brings Leading Experts to Share Practical Pearls
Joe Gorelick, MSN, FNP-C, discusses upcoming highlights and new data expected at the upcoming DERM 2025 CME Conference.
Jacob Thyssen, PhD, on Tackling Hard-to-Treat Hand Eczema
Jacob Thyssen, PhD, discusses tralokinumab's promising results for hand eczema, highlighting its potential to transform treatment options for patients.
Castle Biosciences’ DecisionDx-Melanoma Test Earns FDA Breakthrough Device Designation
Castle Biosciences’ DecisionDx-Melanoma test plays a role in melanoma management with precise risk stratification, enhancing patient outcomes and reducing unnecessary surgeries.
Personalizing Psoriasis Care Across Varying Patient Profiles
Tildrakizumab, HCP-administered biologics, and lifestyle-based decision-making took center stage in an interactive discussion led by Omar Noor, MD, FAAD, and colleagues.
Poll: Are You Attending the 50th Annual Society for Pediatric Dermatology Conference?
We want to know: Will you be attending the conference in Seattle this week?
Journal Digest: July 23, 2025
This review of the latest dermatologic studies includes insights into pruritus as an indicator for QoL in CTCL, the research landscape of acquired dermal macular hyperpigmentation, and more.
